Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

Clinical trial NCT06445322 · RECRUITING

Trial details

NCT number: NCT06445322
Sponsor: Ascidian Therapeutics, Inc
Status: RECRUITING
Study type: OBSERVATIONAL

Stargardt Disease Stargardt Disease 1 Cone Rod Dystrophy Juvenile Macular Degeneration

Start date: 2024-06-20
Primary completion: 2027-08-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.